FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/09/027751 [Registered on: 11/09/2020] Trial Registered Prospectively
Last Modified On: 05/09/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Result of polyherbal Leha for children suffering from stuttering 
Scientific Title of Study   A comparative study of Guduchyadi Leha and Kalyanak Leha in management of Gadgada (Stuttering) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Megha Dipak Rudey 
Designation  PG Scholar 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha  
Address  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  7057291880  
Fax    
Email  megharudey121@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Renu Bharat Rathi 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha  
Address  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9373703816  
Fax    
Email  rbr.226@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Renu Bharat Rathi 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha  
Address  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9373703816  
Fax    
Email  rbr.226@gmail.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College Hospital and Research Center  
Address  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha, Maharashtra, 442001, India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Megha Dipak Rudey  Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha  Kaumarbhritya Department, Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod (Hi), Wardha
Wardha
MAHARASHTRA 
7057291880

megharudey121@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, Salod (H), Wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F01-F99||Mental, Behavioral and Neurodevelopmental disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Guduchyadi Leha  dose - 2-5 years: 0.5 - 1 gm TDS 6-12 years: 2.5 gm BD Anupan - Honey Jivha Pratisarana Duration up to 2 minutes for 45 days Follow-up on 15th, 30th, 45th day  
Comparator Agent  Kalyanak Leha  Dose and Frequency - 2-5 years: 0.5 -1 gm TDS 6-12 years: 2.5 gm BD Anupan - Honey Jivha Pratisarana Duration up to 2 minutes for 45 days Follow-up - 15th, 30th, 45th day  
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  a. Patients with age group of 2 years to 12 years will be taken.
b. Children with clinical manifestations of speech impairment i.e. stuttering will include in the study.
c. Patients will be selected irrespective of gender, religion, socioeconomic status.
d. Patients with diagnosed delayed development of speech as sequel of neurological disorder which is cured.
 
 
ExclusionCriteria 
Details  a. Deaf children will be excluded
b. Children with severe infection, brain trauma
c. Patients suffering from cleft palate & cleft lip or the conditions where the surgical intervention is required
d. Patient suffering from Stomatitis.
e. Children not speaking small sentence.
f. Children suffering from Autism Spectrum disorder.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in the Speech fluency along with reduction of pitch, frequency and duration of the stuttered words or the tone of the stutterer is expected.  15th, 30th, 45th day 
 
Secondary Outcome  
Outcome  TimePoints 
Frequency of stuttering, Duration of stuttering will be reduced, Physical Concomitants, Speech naturalness will improved   15th, 30th, 45th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/10/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, double blind, parallel group study comparing the safety and efficacy of Guduchyadi leha and Kalyanak Leha  in the childrens who are suffering from stuttering. This study will be conducted in Mahtama Gandhi Ayurved College, Hospital and Research Center, Salod (Hi). The outcome of the this study will be reduction in the stuttering in 45 days of treatment period. 
Close